FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion

被引:116
|
作者
Benlimame, N
He, Q
Jie, S
Xiao, DZ
Xu, YJ
Loignon, M
Schlaepfer, DD
Alaoui-Jamali, MA [1 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ H3T 1E2, Canada
[3] Scripps Res Inst, La Jolla, CA 92037 USA
来源
JOURNAL OF CELL BIOLOGY | 2005年 / 171卷 / 03期
关键词
D O I
10.1083/jcb.200504124
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The overexpression of members of the ErbB tyrosine kinase receptor family has been associated with cancer progression. We demonstrate that focal adhesion kinase (FAK) is essential for oncogenic transformation and cell invasion that is induced by ErbB-2 and -3 receptor signaling. ErbB-2/3 overexpression in FAK-deficient cells fails to promote cell transformation and rescue chemotaxis deficiency. Restoration of FAK rescues both oncogenic transformation and invasion that is induced by ErbB-2/3 in vitro and in vivo. In contrast, the inhibition of FAK in FAK-proficient invasive cancer cells prevented cell invasion and metastasis formation. The activation of ErbB-2/3 regulates FAK phosphorylation at Tyr-397, -861, and -925. ErbB-induced oncogenic transformation correlates with the ability of FAK to restore ErbB-2/3-induced mitogen-activated protein kinase ( MAPK) activation; the inhibition of MAPK prevented oncogenic transformation. In contrast, the inhibition of Src but not MAPK prevented ErbB-FAK-induced chemotaxis. In migratory cells, activated ErbB-2/3 receptors colocalize with activated FAK at cell protrusions. This colocalization requires intact FAK. In summary, distinct FAK signaling has an essential function in ErbB-induced oncogenesis and invasiveness.
引用
收藏
页码:505 / 516
页数:12
相关论文
共 50 条
  • [21] Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes
    Altenschmidt, U
    Kahl, R
    Moritz, D
    Schnierle, BS
    Gerstmayer, B
    Wels, W
    Groner, B
    CLINICAL CANCER RESEARCH, 1996, 2 (06) : 1001 - 1008
  • [22] EXPRESSION OF P160(ERBB-3) AND P185(ERBB-2) IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATIC ADENOCARCINOMA
    MYERS, RB
    SRIVASTAVA, SS
    OELSCHLAGER, DK
    GRIZZLE, WE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (15) : 1140 - 1145
  • [23] Prophylactic effects of secretion metabolites of dairy lactobacilli through downregulation of ErbB-2 and ErbB-3 genes on colon cancer cells
    Faghfoori, Zeinab
    Gargari, Bahram Pourghassem
    Saber, Amir
    Seyyedi, Maryam
    Fazelian, Siavash
    Khosroushahi, Ahmad Yari
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (03) : 201 - 209
  • [24] Dynamics of the transmembrane domain of the ErbB-2 receptor
    Duneau, JP
    Crouzy, S
    Chapron, Y
    Genest, M
    THEORETICAL CHEMISTRY ACCOUNTS, 1999, 101 (1-3) : 87 - 91
  • [25] Dynamics of the transmembrane domain of the ErbB-2 receptor
    Jean-Pierre Duneau
    Serge Crouzy
    Yves Chapron
    Monique Genest
    Theoretical Chemistry Accounts, 1999, 101 : 87 - 91
  • [26] ErbB-3 receptor signaling mediates neuregulin-induced cell motility and morphogenesis
    Chausovsky, A
    Elbaum, M
    Geiger, B
    Bershadsky, AD
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 290A - 290A
  • [27] ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
    GrausPorta, D
    Beerli, RR
    Daly, JM
    Hynes, NE
    EMBO JOURNAL, 1997, 16 (07): : 1647 - 1655
  • [28] erbB-2和erbB-3在涎腺腺样囊性癌中的表达及临床病理相关性
    毕玮
    余优成
    潘红芽
    田臻
    孙健
    王庆
    复旦学报(医学版), 2009, 36 (04) : 461 - 464
  • [29] erbB-2与erbB-3在舌鳞状细胞癌中的表达及临床意义
    毕玮
    余优成
    潘红芽
    田臻
    孙健
    王庆
    中国临床医学, 2009, 16 (03) : 462 - 464
  • [30] Cooperative signaling between α6β4 integrin and ErbB-2 receptor is required to promote PI3-kinase-dependent invasion
    Gambaletta, D
    Marchetti, A
    Benedetti, L
    Mercurio, AM
    Sacchi, A
    Falcioni, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) : 1142 - 1142